BAY 607550
| 中文名称 | BAY 607550 |
|---|---|
| 中文同义词 | 化合物 BAY 60-7550;化合物 BAY 60-7550,10 MM DMSO 溶液;Bay 60-7550 抑制剂;化合物:Bay 60-7550 CAS:439083-90-6;Bay 60-7550 抑制剂;化合物：Bay 60-7550 CAS:439083-90-6 |
| 英文名称 | BAY 60-7550 |
| 英文同义词 | BAY 60-7550;2-(3,4-Dimethoxybenzyl)-7-((2R,3R)-2-hydroxy-6-phenylhexan-3-yl)-5-methylimidazo[5,1-f][1,2,4];2-[(3,4-Dimethoxyphenyl)methyl]-7-[(1R)-1-[(1R)-1-hydroxyethyl]-4-phenylbutyl]-5-methyl-imidazo[5,1-f][1,2,4]triazin-4(1H)-one;Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[(3,4-dimethoxyphenyl)methyl]-7-[(1R)-1-[(1R)-1-hydroxyethyl]-4-phenylbutyl]-5-methyl-;Bay 60-7550, 10 mM in DMSO |
| CAS号 | 439083-90-6 |
| 分子式 | C27H32N4O4 |
| 分子量 | 476.57 |
| EINECS号 | |
| 相关类别 | Bases & Related Reagents;Inhibitors;Intermediates & Fine Chemicals;Nucleotides;Pharmaceuticals;Cyclic Nucleotide related |
| Mol文件 | 439083-90-6.mol |
| 结构式 |  |
BAY 607550 性质
| 沸点 | 680.7±65.0 °C(Predicted) |
|---|---|
| 密度 | 1.24±0.1 g/cm3(Predicted) |
| 储存条件 | -20°C |
| 溶解度 | DMSO:21.65(最大浓度 mg/mL);45.43(最大浓度 mM) 乙醇:10.0(最大浓度 mg/mL);20.98(最大浓度 mM) |
| 形态 | 粉末 |
| 酸度系数(pKa) | 14.54±0.20(Predicted) |
| 颜色 | 白色至浅棕色 |
| InChIKey | MYTWFJKBZGMYCS-NQIIRXRSSA-N |
| SMILES | [n]21[nH]c(n[c](c2c(nc1[C@H]([C@H](O)C)CCCc4ccccc4)C)=O)Cc3cc(c(cc3)OC)OC |
Ki: 3.8±0.2 nM (PDE2)
Bay 60-7550 (1 μM) increases cGMP in the neuronal cultures compared with control [F(6,14)=12.97, p<0.05 for Bay 60-7550]. Bay 60-7550 in the presence of NMDA (30 μM) results in further increases in cGMP compared with NMDA alone. The NMDA receptor antagonist MK-801 (10 μM) blocks both Bay 60-7550+NMDA-induced elevation in cGMP in neuronal cultures. Compared with untreated control cells, proliferation of PASMCs from IPAH patients is significantly reduced by BAY 60-7550 (1 μM).
The PDE2 inhibitors Bay 60-7550 (1 mg/kg) reverses restraint stress-induced alterations in behavior, resulting in increased percentages of open-arm entries and open-arm time compared with the vehicle + restraint stress condition. In nonstressed mice, Bay 60-7550 produces a dose-dependent increase in percentages of open-arm entries and open-arm time compared with the vehicle-treated group; significant increases are observed at a dose of 3 mg/kg. In nonstressed mice, Bay 60-7550 increases, in a dose-dependent manner, the number of head-dips and time spent head-dipping, compared with vehicle-treated mice; significant increases are observed at doses of 1 and 3 mg/kg.
安全信息
| WGK Germany | WGK 3 |
|---|---|
| 存储类别 | 11 - 可燃固体 |
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026/06/05 | HY-14992 | Bay 60-7550 | 439083-90-6 | 1 mg | 575元 |
| 2026/06/05 | HY-14992 | BAY 607550 Bay 60-7550 | 439083-90-6 | 5mg | 1150元 |